SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-16-119755
Filing Date
2016-05-10
Accepted
2016-05-10 16:31:43
Documents
71
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a16-6948_110q.htm 10-Q 951068
2 EX-31.1 a16-6948_1ex31d1.htm EX-31.1 11824
3 EX-31.2 a16-6948_1ex31d2.htm EX-31.2 10516
4 EX-32.1 a16-6948_1ex32d1.htm EX-32.1 8613
  Complete submission text file 0001104659-16-119755.txt   4347580

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT vtae-20160331.xml EX-101.INS 803340
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vtae-20160331.xsd EX-101.SCH 43843
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vtae-20160331_cal.xml EX-101.CAL 47342
8 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT vtae-20160331_lab.xml EX-101.LAB 388313
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vtae-20160331_pre.xml EX-101.PRE 309325
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vtae-20160331_def.xml EX-101.DEF 163079
Mailing Address 502 WEST OFFICE CENTER DR FORT WASHINGTON PA 19034
Business Address 502 WEST OFFICE CENTER DR FORT WASHINGTON PA 19034 215-461-2000
Vitae Pharmaceuticals, Inc (Filer) CIK: 0001157602 (see all company filings)

IRS No.: 043567753 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36617 | Film No.: 161636227
SIC: 2834 Pharmaceutical Preparations